Buy stocks
Invest and track all your stocks in one place.
Glenmark Pharmaceuticals LtdNSE: GLENMARK
NSE: GLENMARK
₹893.90
+31.40
(20 Feb)
+3.6%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹893.90
Today’s high
₹905.00
Today’s low
₹866.90
52W high
₹915.95
52W low
₹414.50
1Y
105.1%
PE
-33.01
PB
2.70
EPS (TTM)
10.53
Dividend yield
0.3%
5Y
8.6%
Market cap
₹25,224.8 Cr
Volume
1,15,258
Average volume
56,239
Insights
GLENMARK has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
GLENMARK price is above its 200 day moving average
GLENMARK PE is in the low end of its range over the past 2 years
GLENMARK PE is in the lowest 10% across all stocks. The market is valuing it as a value stock on an earnings basis.
GLENMARK has negative earnings and hence the PE is not defined
In beta. Send feedback here.
Compare with other stock
Price
₹1,589.10
₹1,052.70
₹893.90
₹1,538.70
₹6,373.05
₹3,709.40
1D
+0.1%
+1.2%
+3.6%
+0.6%
-0.7%
-0.4%
1Y
+137.2%
+122.5%
+105.1%
+56.4%
+41.3%
+31.1%
PE
40.56
22.28
-33.01
41.47
20.34
71.18
PB
5.47
2.19
2.70
6.17
3.96
7.77
EPS
39.18
47.24
-27.08
37.10
313.29
52.11
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2022
Revenue
₹12,725.4 Cr
Net income
₹297.2 Cr
See stock holdings
Top institutional holders
Capital Research and Management Company
5.44%
Aditya Birla Sun Life AMC Ltd
2.66%
HDFC Asset Management Co Ltd
2.48%
HDFC Asset Management Company Limited
2.34%
Templeton Asset Management Ltd.
1.88%
Top mutual fund holders
American Funds SMALLCAP World Fund
4.84%
HSBC Pooled Asia Pac ex Jpn Eq Idx TrkFd
3.53%
Aditya BSL Flexi Cap
1.74%
HSBC GIF Asia ex Japan Equity
1.04%
HDFC Capital Builder Value Fund
0.88%
About Glenmark Pharma
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.
Company address
Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Mumbai, , 400099
Key executives
Name
Title
Age
Mr. Glenn Saldanha
CEO/Chairman of the Board/Director/Managing Director
NA
Mr. V. S. Mani
CFO/Director
NA
Ms. Cherylann Pinto
Director/Other Corporate Officer
NA

FAQs

How to Buy Glenmark Pharmaceuticals Ltd Stock?
What is the Share Price of Glenmark Pharmaceuticals Ltd?
What is the Market Cap of Glenmark Pharmaceuticals Ltd?
In which sector / industry does Glenmark Pharmaceuticals Ltd operate?
What was the revenue of Glenmark Pharmaceuticals Ltd?
What is the PE ratio of Glenmark Pharmaceuticals Ltd?
What is the 52 week high price of Glenmark Pharmaceuticals Ltd?
What is the 52 week low price of Glenmark Pharmaceuticals Ltd?
Can fractional shares of Glenmark Pharmaceuticals Ltd be purchased?